Prescription Drug Prices

AARP and AARP Foundation are getting involved in a lawsuit between Merck Co. and the Department of Health and Human Services (HHS) over Medicare’s new authority to negotiate lower prescription drug prices....

A provision of the Inflation Reduction Act of 2022 will slash Medicare Part B co-insurances for 27 drugs between $2 and $390 per average dose beginning April 1. Certain vaccine cost-sharing will also be...

Inflation Reduction Act a welcome step, provider group says … CIDRAP: U.S. COVID cases show signs of decline, but deaths are up … Fatigue and headache among top post-COVID neuropsychiatric symptoms...

The Democrats’ deal also would limit insulin costs and cap annual out-of-pocket spending at $2,000 for seniors. Pharmacy benefit managers would face transparency requirements as well.

House democrats reach deal to reduce prescription drug prices … Watch for recycled medical gloves, feds warn healthcare facilities … CMS incentive programs tied to 6% decline in hospital C. diff infections...

TV ads linked to increased prescription drug use in older adults … ‘High-cost drugs with little clinical value’: Employers plead for drug pricing controls after Aduhelm approval … Key clinical...

President Donald Trump’s “blueprint” for lowering prescription costs goes after pharmacy benefit managers but stops short of recommending Medicare-negotiated prices, a plank he campaigned...